The value of Innovative Medicine: The clinical and economic impact of the first gene therapy for hemophilia B
Content provided by CSL Behring. Copyright 2023 and published by MJH Life Sciences®. No portion of this program may be reproduced or transmitted in any form, by any means, without the prior written permission of MJH Life Sciences. The views and opinions expressed in this material do not necessarily reflect the views and opinions of MJH Life Sciences, or Managed Healthcare Executive®.
Advertorial: The value of Innovative Medicine. The clinical and economic impact of the first gene therapy for hemophilia B
Kindred Hospitals: A Critical Level of Care
August 8th 2024Intensive Care Units in long-term acute care hospitals (LTACHs) treat many of the same conditions that traditional ICUs treat but are designed to do so for a longer period of time. Not only is it possible for LTACHs to treat patients with these conditions but these specialized hospitals are also able to achieve lower readmission rates for more complex patients. In this article you will discover: · The top conditions treated at both traditional ICUs and LTACHs · Readmission rates of complex patients discharging from both settings · Characteristics of Kindred Hospitals’ LTACHs that allow them to provide exceptional critical care
Read More
